Home › Funds › SABBY MANAGEMENT, LLC › REVB

SABBY MANAGEMENT, LLC position in REVB

REVELATION BIOSCIENCES INC · Health Care

SABBY MANAGEMENT, LLC reported holding 126,915 shares of REVB (REVELATION BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$104K, representing 2.30% of its reported portfolio and ranking #14 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed REVB holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)126.92K sh
Reported value held$103.69K
Portfolio Weight2.30%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SABBY MANAGEMENT, LLC's REVB position evolved

SABBY MANAGEMENT, LLC first disclosed a stake in REVB in Q3 2023 at 403,233 shares (US$278.0M). Across 9 filings, SABBY MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 126,915 shares valued at US$104K — a reduction of -83,667 shares quarter over quarter.. Notable position changes include a 215% increase in Q3 2025 (shares fell 44% over the following quarter), a 193% increase in Q4 2025 (shares fell 63% over the following quarter), a 112% increase in Q2 2026 (shares fell 89% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 403.23K $277.99M New
Q4 2023 403.23K $201.90M Hold
Q3 2024 42.23K $35.97K New
Q2 2025 65.79K $49.34K New
Q3 2025 207.05K $294.01K Add
Q4 2025 605.70K $484.44K Add
Q1 2026 99.43K $119.32K Reduce
Q2 2026 210.58K $216.90K Add
Q3 2026 126.92K $103.69K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REVB and 13F data

REVB (REVELATION BIOSCIENCES INC) is a Health Care company. 13 other funds we track also report a position in REVB. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REVB

No other tracked fund reports a position in REVB.

All REVB fund holders →

FAQ

How long has SABBY MANAGEMENT, LLC held REVB?

SABBY MANAGEMENT, LLC has disclosed REVB holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is SABBY MANAGEMENT, LLC's current position in REVB?

As of Q3 2026, SABBY MANAGEMENT, LLC holds 126.92K shares of REVB (REVELATION BIOSCIENCES INC), valued at $103.69K, representing 2.30% of its reported portfolio and ranking #14.

Has SABBY MANAGEMENT, LLC been buying or selling REVB?

In the latest 13F filing (Q3 2026), SABBY MANAGEMENT, LLC reduced its position in REVB.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.